11 May Master Class: Free DCT Certification

Decentralised Clinical Trial (DCT) Master Class: Equip your studies for digital success in 2022

May 11th, 2022 | 11-12 CET

Space is limited. Reserve now.

This master class is for sponsors or biotech professionals who want to become certified experts in hybrid and decentralised clinical trial (DCT) design. 

By the end of the class, you'll be able to: 

  • Convey critical elements and best practices for implementing DCTs for customers
  • Implement best practices for digital strategies in studies
  • Explain how DCTs operate at both the site and patient levels
  • Improve patient enrollment, engagement, and retention 
  • Reduce overall delivery timelines and costs
  • Share your DCT certification badge to your social media accounts (i.e., LinkedIn, Twitter) and add it to your email signature

Plus, learn firsthand what Tufts CSDD's new report says about decreases in clinical trial cycle times, screen failure rates, and substantive protocol elements that help drive:

  • Phase II studies - Possible net benefits up to 5x greater than the upfront investment required.
  • Phase III studies - Possible net benefits up to 13x greater than the upfront investment required.

Join Medable's Vice President of DCT, Claire Marsden, and Senior Director of Business Development, Chris Tutill, for what will surely be an engaging and informative master class.

Learn from the No. 1 DCT provider in the industry!

Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.

Chris Tutill is a Senior Director of Business Development at Medable.

Save the Date!